The Covid-19 vaccination campaign in the UAE is progressing at a rapid pace, with the country having achieved an inoculation rate of 85.85 doses per 100 people.
Individuals with low immune response against Covid-19 may require a third dose of vaccination to improve development of antibodies, the health authorities said recently.
The Head of Emirates Stem Cells Group, Sheikha al Mazrouei explained that recently the health authorities requested few individuals to receive a third dose of the Covid-19 vaccine as they were unable to develop sufficient antibody levels against the virus.
During a meeting organized by the Maitha Bint Ahmed Al Nahyan Foundation aimed at increasing awareness on the Covid-19 vaccination campaign, Al Mazrouei mentioned that health authorities have already told a small section of residents to review their antibody levels after three weeks of receiving the second dose.
"The UAE is proceeding with confident steps to fight the coronavirus, and has taken proactive measures to prevent the spread of the epidemic by following the recommended preventive measures, as well as providing vaccines against the virus,” said Al Mazrouei, who was quoted in local Arabic media on Monday.
The SARS-CoV-2 Vaccine (Vero Cell) is an inactivated biotechnology product meant to protect people against the Covid-19 virus.
At present, the approved Covid-19 vaccines in the country are Sinopharm (SARS-CoV-2 Vaccine Inactivated Vaccine), Pfizer / BioNTech (mRNA) and Sputnik V, as per the UAE National Emergency Crisis and Disasters Management Authority (NCEMA).
